VC  Flagship Pioneering

https://www.flagshippioneering.com/





     Office Locations:

55 Cambridge Parkway, Suite 800E
Cambridge, MA 02142
Phone: 617-868-1888
Fax: 617-868-1115

 

Stages:

  • Early
  • Seed


 

Industries:

  • Energy & Clean Tech
  • Food & Agriculture
  • Life Sciences & Healthcare

  •  

    Description:

    Founded in 2000, Flagship Pioneering (f/k/a Flagship Ventures) is an entrepreneurship and venture capital firm based in Cambridge, MA. The Flagship investment team consists of 10 professionals focused on creating, financing, and building companies in the Therapeutics, Life Science & Diagnostics, and BioEnergy/Cleantech sectors. Flagship has funded more than 100 scientific ventures, resulting in $30 billion in aggregate value. Flagship's initial investment may range between $500,000 and $5 million. The firm may invest up to a total $7-$15 million during the life of an early stage venture and typically forms a syndicate that includes other leading venture firms. The firm announced in March of 2015 that it raised $537 million for Flagship Ventures Fund V, its largest fund since its founding in 2000. The new investment brought Flagship's aggregate funds under management to $1.4 billion at the time. Since 2000, Flagship Pioneering has raised $2.5 billion across six investment funds and has deployed about $1.4 billion to power the next generation of breakthrough innovations that can transform the world. 6 to 8 new companies are invested in each year.


     

    Funds:


      Fund Name


      Amount


      Date

    Get funds under management for this firm including Fund name, Dollar size of fund raise, and Vintage with a National Database subscription.



    Investment Firm Key

       VC = Venture Capital
       PE = Private Equity
       A = Angel
       I = Incubator
       MB = Merchant Bank
       VD = Venture Debt
       FI = Family Investment Office
       FOF = Fund of Funds
       ED = Economic Development Office   
       TT = Technology Transfer Office
       CVC = Corporate Venture Capital
       SEC = Secondary Purchaser
       HF = Hedge Fund/Mutual Fund
       
       
       
    COMPANY STAGEREVENUE
    Venture Capital
    Seed Stage
    (includes "pre-seed," or
    concept stage)
    No Revenue
    Early StageMinimal
    Revenue
    Growth Stage
    (also called Mid-stage)
    $2M-$7M
    Expansion Stage
    (also called Late-stage)
    $7M and greater
    Private Equity
    Lower Middle Market$10M-$249M
    Middle Market$250M-$499M
    Upper Middle Market$500M-$1B
    Large Cap>$1B
       
       
     

    Investment Team:


    Name   Title
    Get the complete investment team + individual email addresses for investment team partners. Get personal images, LinkedIn links, investment specialties, office locations and more with a National Database subscription.
    Avak Kahvejian General Partner
    Bernard P. Cooney Senior Partner
    Christopher Austin CEO-Partner
    Chuck Carelli Chief Financial Officer & Executive Partner
    Doug Cole Managing Partner

     

    Recent Funding Events (trailing 12 months):


      Date


      Name


      State


      Amount


      Stage


      05/17/2024


      Prologue Medicine


      MA


      $50,000,000


      


     

    Portfolio companies include:


      Alltrna
        web link


      Apriori Bio
        web link


      Boragen


      Cellarity


      Denali Therapeutics


      Empress Therapeutics
        web link


      Evelo Biosciences


      Foghorn Therapeutics
        web link


      Generate:Biomedicines
        web link


      Harbinger Health
        web link


      Inari
        web link


      Indigo
        web link


      Korrus


      KSQ Therapeutics
        web link


      Moderna


      Omega Therapeutics


      ProFound Therapeutics
        web link


      Prologue Medicine
        web link


      Ring Therapeutics
        web link


      Rubius Therapeutics
        web link


      Sana Biotechnology


      Senda Biosciences
        web link


      Seres Therapeutics


      Sigilon Therapeutics
        web link


      Sonata Therapeutics


      Syros Phamaceuticals


      Tessera Therapeutics
        web link


      Valo Health
        web link


      Vesalius Therapeutics
        web link


      Visterra
        web link


      YourBio Health


     

    Recent News: